Blairy, S., & Pinto, E. (2015). Il n'existe aucun traitement efficace de l'alcoolisme? In V. Seutin, J. Scuvée-Moreau, ... E. Quertemont, L'alcool en questions (pp. 129-141). Bruxelles, Belgium: Mardaga. |
Blairy, S., & Pinto, E. (2015). Il n'existe aucun traitement efficace de l'alcoolisme? In V. Seutin, J. Scuvée-Moreau, ... E. Quertemont, L'alcool en questions (pp. 129-141). Bruxelles, Belgium: Mardaga. |
PITCHOT, W., SCANTAMBURLO, G., Pinto, E., & Karila L. (2013). Addiction à la cocaine. Revue Médicale de Liège. |
PITCHOT, W., & Pinto, E. (2011). Réunion de consensus sur la procédure de mise en observation. Acta Psychiatrica Belgica, 211. |
BEVE, A., BECK, E., Pinto, E., & Ansseau, M. (2010). Le cas clinique du mois. Syndrome de sécrétion inappropriée d'hormone antidiurétique (SIADH) induit par le valproate de sodium. Revue Médicale de Liège, 65 (1), 6-9. |
Farcy, L., PIETTE, C., MAVROPOULOS, G., Pinto, E., Ansseau, M., & PITCHOT, W. (2010). Delirium et anorexie. Acta Psychiatrica Belgica, 110, 3-7. |
PITCHOT, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2010). Guérir la dépression : une question d'objectif et de détermination. Revue Médicale de Liège, 65 (5-6), 370-380. |
Scantamburlo, G., Reggers, J., Hansenne, M., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2010). Ocytocine plamsatique et dimensions de personnalité dans la dépression unipolaire. Encéphale (L'), 36, 17. |
Pinto, E., & Ansseau, M. (2009). Facteurs genetiques de l'alcoolo-dependance Revue des principales donnees de la litterature. Encéphale (L'), 35 (5), 461-9. doi:10.1016/j.encep.2008.03.008 |
Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? Alcohol, 43 (4), 271-5. doi:10.1016/j.alcohol.2009.02.006 |
Ansseau, M., Scantamburlo, G., Pinto, E., & Pitchot, W. (2008). Neurobiologie et pharmacothérapie du trouble obsessionnel-compulsif. Revue Médicale de Liège, 63, 359-363. |
Maquet, D., Jaspar, J., Lecart, M.-P., Faymonville, M., Crielaard, J.-M., Bève, E., Ansseau, M., Pinto, E., Haidon, M., & Croisier, J.-L. (2008). La marche du sujet fibromyalgique et d’un sujet dépressif est-elle différenciable ? Exploration de deux affections « voisines » à partir d’un accéléromètre tri-axial. Revue du Rhumatisme, 75, 1142. |
Pinto, E., Pitchot, W., & Ansseau, M. (2008). Les psychostimulants. Revue Médicale de Liège, 63, 411-416. |
Pinto, E., Reggers, J., Gorwood, P., BONI, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008). The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol and Alcoholism, 43, 398-400. doi:10.1093/alcalc/agn015 |
Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008). Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior. Journal of Psychiatric Research, 42, 684-688. doi:10.1016/j.jpsychires.2007.07.007 |
Pitchot, W., Pinto, E., Scantamburlo, G., & Ansseau, M. (March 2007). Duloxetine in major depressed patients resistant to SSRIs or venlafaxine. European Psychiatry, 22 (Suppl. 1), 242. doi:10.1016/j.eurpsy.2007.01.810 |
Coton, X., Pinto, E., Reggers, J., Hansenne, M., Parent, M., & Ansseau, M. (2007). Impact de la personnalité sur l'intensité du syndrome de sevrage alcoolique : une étude préliminaire avec le modèle de Cloninger. Encéphale (L'), 33, 264-269. doi:10.1016/s0013-7006(07)92038-2 |
Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4. |
Scantamburlo, G., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2007). Therapeutic utilisations of vasopressin and oxytocin in mood disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 1, 157-161. |
Pinto, E. (2006). Craving for alcohol : a psychogenetic approach [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314800 |
Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology, 30 (9), 839-845. doi:10.1016/j.psyneuen.2005.04.015 |
Pinto, E., Gorwood, P., Reggers, J., Vaira, D., Fuchs, S., & Pitchot, W. (March 2005). Alcohol craving and the A1 allele of the D2 dopamine receptor gene. European Psychiatry, 20 (Suppl. 1), 25. |
Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2005). 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry, 58 (11), 854-8. doi:10.1016/j.biopsych.2005.05.042 |
Fuchs, S., Reggers, J., Pinto, E., Scantamburlo, G., Pitchot, W., Hansenne, M., Maertens De Noordhout, A., & Ansseau, M. (October 2004). Therapeutic application of right prefrontal low repetitive transcranial magnetic stimulation on depressed patients. European Neuropsychopharmacology, 14 (Suppl. 3), 226. doi:10.1016/S0924-977X(04)80206-2 |
Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2004). Neurohypophyseal response to apomorphine and clonidine stimulation in major depression. European Neuropsychopharmacology, 14 (Suppl. 3), 291-S292. doi:10.1016/S0924-977X(04)80355-9 |
Pinto, E., & Ansseau, M. (May 2004). Les alcoolisations paroxystiques. Revue Médicale de Liège, 59 (5), 297-300. |
Charlier, C., Broly, F., Pinto, E., Ansseau, M., Plomteux, G., & Lhermitte, M. (December 2003). Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine. Therapeutic Drug Monitoring, 25 (6), 738-742. doi:10.1097/00007691-200312000-00014 |
Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5 |
De Witte, P., Pinto, E., Ansseau, M., & Verbanck, P. (May 2003). Alcohol and withdrawal: from animal research to clinical issues. Neuroscience and Biobehavioral Reviews, 27 (3), 189-197. doi:10.1016/S0149-7634(03)00030-7 |
Hansenne, M., Olin, C., Pinto, E., Pitchot, W., & Ansseau, M. (2003). Event-related potentials to emotional and neutral stimuli in alcoholism. Neuropsychobiology, 48 (2), 77-81. doi:10.1159/000072881 |
Hansenne, M., Pinto, E., Scantamburlo, G., Couvreur, A., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology, 18 (3), 201-5. doi:10.1002/hup.468 |
Hansenne, M., Pinto, E., Scantamburlo, G., Renard, B., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Harm avoidance is related to mismatch negativity (MMN) amplitude in healthy subjects. Personality and Individual Differences, 34 (6), 1039-1048. doi:10.1016/S0191-8869(02)00088-0 |
Pinto, E., Reggers, J., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2003). Toxicomanes: sevrage ultrarapide aux opiacés sous anesthésie générale au CHU de Liège. Agenda Psychiatrie, 28, 1-2. |
Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., & Ansseau, M. (2003). Catecholamine and HPA axis dysfunction in depression : relationship with suicidal behavior. Neuropsychobiology, 47 (3), 152-157. doi:10.1159/000070585 |
Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (December 2002). Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients. Journal of Psychopharmacology, 16 (4), 369-372. doi:10.1177/026988110201600413 |
Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J.-J., & Ansseau, M. (October 2002). Hormonal and temperature responses to the 5-HT1a receptor agonist flesinoxan in normal volunteers. Psychopharmacology, 164 (1), 27-32. doi:10.1007/s00213-002-1177-0 |
Hansenne, M., Pinto, E., Pitchot, W., Reggers, J., Scantamburlo, G., Moor, M., & Ansseau, M. (2002). Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Personality and Individual Differences, 33 (6), 967-977. doi:10.1016/S0191-8869(01)00205-7 |
Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., & Ansseau, M. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychological Medicine, 32 (5), 935-41. doi:10.1017/S0033291702005445 |
Pinto, E., Reggers, J., PITCHOT, W., Hansenne, M., Fuchs, S., & Ansseau, M. (2002). Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. Psychoneuroendocrinology, 27 (7), 873-879. doi:10.1016/S0306-4530(01)00088-9 |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., & Ansseau, M. (October 2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26 (7), 689-696. doi:10.1016/S0306-4530(01)00021-X |
PITCHOT, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., & Ansseau, M. (April 2001). Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology, 26 (3), 331-335. doi:10.1016/S0306-4530(00)00047-0 |
Pinto, E., Reggers, J., Delhez, M., Fuchs, S., VENNEMAN, I., Lamy, M., & ANSSEAU, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaciés sous anesthiésie géniérale: Résultats préliminaires du protocole Liègeois. Revue Médicale de Liège, 56 (8), 572-576. |
Pinto, E., Reggers, J., Delhez, M., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaces sous anesthésie générale: resultats préliminaires du protocole liégeois. Revue Médicale de Liège, 56 (8), 572-576. |
Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2001). Alpha-2-adrenoreceptors in depressed suicide attempters : relationship with medical lethality of the attempt. Neuropsychobiology, 44 (2), 91-94. doi:10.1159/000054923 |
Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (August 2000). Relationship between Clinical Effects, Serum Drug Concentration, and Concurrent Drug Interactions in Depressed Patients Treated with Citalopram, Fluoxetine, Clomipramine, Paroxetine or Venlafaxine. Human Psychopharmacology, 15 (6), 453-459. doi:10.1002/1099-1077(200008)15:6<453::AID-HUP228>3.0.CO;2-F |
Ansseau, M., Besson, J., Lejoyeux, M., Pinto, E., Landry, U., Cornes, M., Deckers, F., Potgieter, A., & Ades, J. (2000). A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: A validation study in Belgium, France, and Switzerland. European Addiction Research, 6 (2), 51-6. doi:10.1159/000019010 |
Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2 |
Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8 |
Papart, P., WEERTS, P., Pinto, E., Hansenne, M., & Ansseau, M. (2000). Relationship between CNV topography and irritability in depression. Journal of Psychophysiology, 14 (Suppl 1). |
Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1999). Le controle thérapeutique des médicaments antidépresseurs. Annales de Biologie Clinique, 57 (4, Jul-Aug), 463-8. |
Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamier, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33 (1), 31-6. doi:10.1016/S0022-3956(98)00036-3 |
Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1997). Manifestations indésirables des antidépresseurs. Toxicorama, (Spécial LYON), 310-314. |